Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	cell-cell adhesion mediator activity	EPCAM DSP	1.52e-03	61	19	2	GO:0098632
GeneOntologyMolecularFunction	cell adhesion mediator activity	EPCAM DSP	2.34e-03	76	19	2	GO:0098631
GeneOntologyMolecularFunction	single-stranded DNA binding	BRCA2 MSH2	7.09e-03	134	19	2	GO:0003697
GeneOntologyMolecularFunction	tubulin binding	BRCA2 CENPE HAUS6	7.34e-03	428	19	3	GO:0015631
GeneOntologyBiologicalProcess	cell cycle checkpoint signaling	BRCA2 CENPE EME1 MSH2	3.25e-05	217	18	4	GO:0000075
GeneOntologyBiologicalProcess	mitotic intra-S DNA damage checkpoint signaling	EME1 MSH2	9.71e-05	17	18	2	GO:0031573
GeneOntologyBiologicalProcess	negative regulation of cell cycle phase transition	BRCA2 CENPE EME1 MSH2	1.31e-04	311	18	4	GO:1901988
GeneOntologyBiologicalProcess	microtubule-based process	BRCA2 FSIP2 CENPE DYNC2I1 HAUS6 DEUP1	1.96e-04	1058	18	6	GO:0007017
GeneOntologyBiologicalProcess	DNA damage checkpoint signaling	BRCA2 EME1 MSH2	2.13e-04	136	18	3	GO:0000077
GeneOntologyBiologicalProcess	negative regulation of cell cycle process	BRCA2 CENPE EME1 MSH2	2.35e-04	362	18	4	GO:0010948
GeneOntologyBiologicalProcess	mitotic recombination	BRCA2 MSH2	2.49e-04	27	18	2	GO:0006312
GeneOntologyBiologicalProcess	DNA integrity checkpoint signaling	BRCA2 EME1 MSH2	2.57e-04	145	18	3	GO:0031570
GeneOntologyBiologicalProcess	meiosis I	BRCA2 CENPE EME1	2.68e-04	147	18	3	GO:0007127
GeneOntologyBiologicalProcess	microtubule cytoskeleton organization	BRCA2 FSIP2 CENPE HAUS6 DEUP1	3.00e-04	720	18	5	GO:0000226
GeneOntologyBiologicalProcess	response to X-ray	BRCA2 MSH2	3.08e-04	30	18	2	GO:0010165
GeneOntologyBiologicalProcess	meiosis I cell cycle process	BRCA2 CENPE EME1	3.13e-04	155	18	3	GO:0061982
GeneOntologyBiologicalProcess	mitotic cell cycle checkpoint signaling	CENPE EME1 MSH2	3.62e-04	163	18	3	GO:0007093
GeneOntologyBiologicalProcess	centrosome cycle	BRCA2 HAUS6 DEUP1	3.69e-04	164	18	3	GO:0007098
GeneOntologyBiologicalProcess	microtubule organizing center organization	BRCA2 HAUS6 DEUP1	4.76e-04	179	18	3	GO:0031023
GeneOntologyBiologicalProcess	negative regulation of cell cycle	BRCA2 CENPE EME1 MSH2	6.02e-04	464	18	4	GO:0045786
GeneOntologyBiologicalProcess	signal transduction in response to DNA damage	BRCA2 EME1 MSH2	6.58e-04	200	18	3	GO:0042770
GeneOntologyBiologicalProcess	intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator	BRCA2 MSH2	8.26e-04	49	18	2	GO:0042771
GeneOntologyBiologicalProcess	regulation of cell cycle phase transition	BRCA2 CENPE EME1 MSH2	8.96e-04	516	18	4	GO:1901987
GeneOntologyBiologicalProcess	replication fork processing	BRCA2 EME1	9.29e-04	52	18	2	GO:0031297
GeneOntologyBiologicalProcess	cell cycle process	BRCA2 CENPE EME1 HAUS6 MSH2 DEUP1	1.03e-03	1441	18	6	GO:0022402
GeneOntologyBiologicalProcess	meiotic nuclear division	BRCA2 CENPE EME1	1.12e-03	240	18	3	GO:0140013
HumanPheno	Cardiac diverticulum	BRCA2 EPCAM MSH2	3.07e-06	18	9	3	HP:0100571
HumanPheno	Glioblastoma multiforme	BRCA2 EPCAM MSH2	7.58e-06	24	9	3	HP:0012174
HumanPheno	T-cell acute lymphoblastic leukemias	BRCA2 MSH2	8.32e-06	3	9	2	HP:0006727
HumanPheno	Pancreatic adenocarcinoma	BRCA2 EPCAM MSH2	2.03e-05	33	9	3	HP:0006725
HumanPheno	Disturbed perception with a stimulus	BRCA2 EPCAM MSH2	2.65e-05	36	9	3	HP:5200204
HumanPheno	Disturbed sensory perception	BRCA2 EPCAM MSH2	2.65e-05	36	9	3	HP:0010524
HumanPheno	Abnormal interpretation of external stimuli	BRCA2 EPCAM MSH2	2.88e-05	37	9	3	HP:5200202
HumanPheno	Colon cancer	BRCA2 EPCAM MSH2	3.38e-05	39	9	3	HP:0003003
HumanPheno	Amaurosis fugax	BRCA2 EPCAM MSH2	3.93e-05	41	9	3	HP:0100576
HumanPheno	Death in early adulthood	EPCAM DSP MSH2	4.23e-05	42	9	3	HP:0100613
HumanPheno	Death in adulthood	EPCAM DSP MSH2	4.87e-05	44	9	3	HP:0033763
HumanPheno	Neoplasm of the rectum	BRCA2 EPCAM MSH2	5.57e-05	46	9	3	HP:0100743
HumanPheno	Glioma	BRCA2 EPCAM MSH2	6.34e-05	48	9	3	HP:0009733
HumanPheno	Pituitary adenoma	BRCA2 EPCAM MSH2	8.07e-05	52	9	3	HP:0002893
HumanPheno	Dysgraphia	BRCA2 EPCAM MSH2	8.55e-05	53	9	3	HP:0010526
HumanPheno	Abnormal uterus morphology	BRCA2 EPCAM DYNC2I1 MSH2	9.94e-05	158	9	4	HP:0031105
HumanPheno	Basal cell carcinoma	BRCA2 EPCAM MSH2	1.12e-04	58	9	3	HP:0002671
HumanPheno	Salivary gland neoplasm	EPCAM MSH2	1.24e-04	10	9	2	HP:0100684
HumanPheno	Laryngeal carcinoma	EPCAM MSH2	1.24e-04	10	9	2	HP:0012118
HumanPheno	Neuroblastoma	BRCA2 EPCAM MSH2	1.30e-04	61	9	3	HP:0003006
HumanPheno	Neuroblastic tumor	BRCA2 EPCAM MSH2	1.30e-04	61	9	3	HP:0004376
HumanPheno	Peripheral primitive neuroectodermal neoplasm	BRCA2 EPCAM MSH2	1.37e-04	62	9	3	HP:0030067
HumanPheno	Neoplasm of the anterior pituitary	BRCA2 EPCAM MSH2	1.58e-04	65	9	3	HP:0011750
HumanPheno	Neoplasm of the pituitary gland	BRCA2 EPCAM MSH2	1.58e-04	65	9	3	HP:0040277
HumanPheno	Primitive neuroectodermal tumor	BRCA2 EPCAM MSH2	1.73e-04	67	9	3	HP:0030065
HumanPheno	Breast carcinoma	BRCA2 EPCAM MSH2	1.73e-04	67	9	3	HP:0003002
HumanPheno	Ovarian neoplasm	BRCA2 EPCAM MSH2	1.97e-04	70	9	3	HP:0100615
HumanPheno	Uterine neoplasm	BRCA2 EPCAM MSH2	2.14e-04	72	9	3	HP:0010784
HumanPheno	Tumours of the breast	BRCA2 EPCAM MSH2	2.23e-04	73	9	3	HP:0010623
HumanPheno	Hepatocellular carcinoma	BRCA2 EPCAM MSH2	2.42e-04	75	9	3	HP:0001402
HumanPheno	Female reproductive system neoplasm	BRCA2 EPCAM MSH2	2.51e-04	76	9	3	HP:0033020
HumanPheno	Neoplasm of the respiratory system	BRCA2 EPCAM MSH2	2.72e-04	78	9	3	HP:0100606
HumanPheno	Neoplasm of the colon	BRCA2 EPCAM MSH2	3.04e-04	81	9	3	HP:0100273
HumanPheno	Neoplasm of the larynx	EPCAM MSH2	3.72e-04	17	9	2	HP:0100605
HumanPheno	Neoplasm of the pancreas	BRCA2 EPCAM MSH2	3.75e-04	87	9	3	HP:0002894
HumanPheno	Neoplasm of the thyroid gland	BRCA2 EPCAM MSH2	3.75e-04	87	9	3	HP:0100031
HumanPheno	Abnormality of intracranial pressure	BRCA2 EPCAM MSH2	4.15e-04	90	9	3	HP:0012640
HumanPheno	Increased intracranial pressure	BRCA2 EPCAM MSH2	4.15e-04	90	9	3	HP:0002516
HumanPheno	Neuroepithelial neoplasm	BRCA2 EPCAM MSH2	4.43e-04	92	9	3	HP:0030063
HumanPheno	Neoplasm of the breast	BRCA2 EPCAM MSH2	4.43e-04	92	9	3	HP:0100013
HumanPheno	Neuroectodermal neoplasm	BRCA2 EPCAM MSH2	4.72e-04	94	9	3	HP:0030061
HumanPheno	Nervous tissue neoplasm	BRCA2 EPCAM MSH2	4.72e-04	94	9	3	HP:0030060
HumanPheno	Neoplasm of the stomach	BRCA2 EPCAM MSH2	5.33e-04	98	9	3	HP:0006753
HumanPheno	Abnormality of the upper respiratory tract	BRCA2 CENPE EPCAM DYNC2I1 DSP NDNF MSH2	5.47e-04	1111	9	7	HP:0002087
HumanPheno	Malignant neoplasm of the central nervous system	BRCA2 EPCAM MSH2	5.49e-04	99	9	3	HP:0100836
HumanPheno	Abnormal stool composition	BRCA2 EPCAM	5.73e-04	21	9	2	HP:0031685
HumanPheno	Abnormality of the uterus	BRCA2 EPCAM DYNC2I1 MSH2	6.43e-04	256	9	4	HP:0000130
HumanPheno	Benign neoplasm of the central nervous system	BRCA2 EPCAM MSH2	6.53e-04	105	9	3	HP:0100835
HumanPheno	Gonadal neoplasm	BRCA2 EPCAM MSH2	7.29e-04	109	9	3	HP:0010785
HumanPheno	Adenoma sebaceum	EPCAM MSH2	8.15e-04	25	9	2	HP:0009720
HumanPheno	Neoplasm of the large intestine	BRCA2 EPCAM MSH2	8.31e-04	114	9	3	HP:0100834
HumanPheno	Abnormality of the ovary	BRCA2 EPCAM NDNF MSH2	8.79e-04	278	9	4	HP:0000137
HumanPheno	Abnormal salivary gland morphology	EPCAM MSH2	8.82e-04	26	9	2	HP:0010286
HumanPheno	Endometrial carcinoma	EPCAM MSH2	8.82e-04	26	9	2	HP:0012114
HumanPheno	Neoplasm of the skeletal system	BRCA2 EPCAM MSH2	9.42e-04	119	9	3	HP:0010622
HumanPheno	Abnormal endometrium morphology	EPCAM MSH2	1.02e-03	28	9	2	HP:0030126
HumanPheno	Fibroma	BRCA2 EPCAM MSH2	1.06e-03	124	9	3	HP:0010614
HumanPheno	Fibrous tissue neoplasm	BRCA2 EPCAM MSH2	1.11e-03	126	9	3	HP:0012316
HumanPheno	Angiofibromas	EPCAM MSH2	1.18e-03	30	9	2	HP:0010615
HumanPheno	Visual field defect	BRCA2 EPCAM CACNA1F MSH2	1.22e-03	303	9	4	HP:0001123
HumanPheno	Renal neoplasm	BRCA2 EPCAM MSH2	1.48e-03	139	9	3	HP:0009726
HumanPheno	Neoplasm of the liver	BRCA2 EPCAM MSH2	1.51e-03	140	9	3	HP:0002896
HumanPheno	Anal atresia	BRCA2 EPCAM DYNC2I1	1.61e-03	143	9	3	HP:0002023
HumanPheno	Urinary tract neoplasm	BRCA2 EPCAM MSH2	1.64e-03	144	9	3	HP:0010786
HumanPheno	Paresthesia	BRCA2 EPCAM MSH2	1.64e-03	144	9	3	HP:0003401
HumanPheno	Abnormal rectum morphology	BRCA2 EPCAM MSH2	1.67e-03	145	9	3	HP:0002034
HumanPheno	Abnormality of the pancreas	BRCA2 EPCAM DYNC2I1 MSH2	1.68e-03	330	9	4	HP:0001732
HumanPheno	Malignant genitourinary tract tumor	EPCAM MSH2	1.69e-03	36	9	2	HP:0006758
HumanPheno	Genital neoplasm	BRCA2 EPCAM MSH2	1.85e-03	150	9	3	HP:0010787
HumanPheno	Acute lymphoblastic leukemia	BRCA2 MSH2	1.89e-03	38	9	2	HP:0006721
HumanPheno	Migraine	BRCA2 EPCAM MSH2	1.99e-03	154	9	3	HP:0002076
HumanPheno	Neoplasm of the endocrine system	BRCA2 EPCAM MSH2	2.03e-03	155	9	3	HP:0100568
HumanPheno	Memory impairment	BRCA2 EPCAM MSH2	2.14e-03	158	9	3	HP:0002354
HumanPheno	Hallucinations	BRCA2 EPCAM MSH2	2.22e-03	160	9	3	HP:0000738
HumanPheno	Renal hypoplasia/aplasia	BRCA2 CENPE DYNC2I1 NDNF	2.30e-03	359	9	4	HP:0008678
HumanPheno	Gastrointestinal hemorrhage	BRCA2 EPCAM MSH2	2.39e-03	164	9	3	HP:0002239
HumanPheno	Soft tissue sarcoma	BRCA2 EPCAM MSH2	2.47e-03	166	9	3	HP:0030448
HumanPheno	Abnormality of the anterior pituitary	BRCA2 EPCAM NDNF MSH2	2.47e-03	366	9	4	HP:0011747
HumanPheno	Anorectal anomaly	BRCA2 EPCAM DYNC2I1 MSH2	2.52e-03	368	9	4	HP:0012732
HumanPheno	Abnormal morphology of female internal genitalia	BRCA2 EPCAM DYNC2I1 NDNF MSH2	2.99e-03	665	9	5	HP:0000008
HumanPheno	Abnormality of the larynx	CENPE EPCAM DYNC2I1 NDNF MSH2	3.01e-03	666	9	5	HP:0001600
HumanPheno	Neoplasm of the central nervous system	BRCA2 EPCAM MSH2	3.02e-03	178	9	3	HP:0100006
HumanPheno	Weight loss	BRCA2 CENPE EPCAM MSH2	3.07e-03	388	9	4	HP:0001824
HumanPheno	Abnormal pituitary gland morphology	BRCA2 EPCAM NDNF MSH2	3.10e-03	389	9	4	HP:0012503
HumanPheno	Abnormal thyroid morphology	BRCA2 EPCAM MSH2	3.26e-03	183	9	3	HP:0011772
HumanPheno	Skeletal dysplasia	EPCAM DYNC2I1 NDNF	3.42e-03	186	9	3	HP:0002652
HumanPheno	Abnormal glial cell morphology	BRCA2 EPCAM MSH2	3.47e-03	187	9	3	HP:0100705
HumanPheno	Craniofacial cleft	BRCA2 EPCAM DYNC2I1 DSP NDNF	3.63e-03	694	9	5	HP:5201015
HumanPheno	Orofacial cleft	BRCA2 EPCAM DYNC2I1 DSP NDNF	3.63e-03	694	9	5	HP:0000202
HumanPheno	Neoplasm of the nervous system	BRCA2 EPCAM MSH2	3.91e-03	195	9	3	HP:0004375
Pathway	KEGG_HOMOLOGOUS_RECOMBINATION	BRCA2 EME1	2.48e-04	28	12	2	M11675
Pathway	REACTOME_RESOLUTION_OF_D_LOOP_STRUCTURES	BRCA2 EME1	3.89e-04	35	12	2	MM15293
Pathway	REACTOME_RESOLUTION_OF_D_LOOP_STRUCTURES	BRCA2 EME1	4.35e-04	37	12	2	M27583
Pathway	REACTOME_RND3_GTPASE_CYCLE	ANKRD62 DSP	5.61e-04	42	12	2	MM15677
Pathway	REACTOME_RND1_GTPASE_CYCLE	ANKRD62 DSP	5.88e-04	43	12	2	MM15679
Pathway	REACTOME_DISEASES_OF_DNA_REPAIR	BRCA2 MSH2	8.28e-04	51	12	2	M29854
Pathway	REACTOME_HDR_THROUGH_HOMOLOGOUS_RECOMBINATION_HRR	BRCA2 EME1	1.11e-03	59	12	2	MM15283
Pathway	REACTOME_HDR_THROUGH_HOMOLOGOUS_RECOMBINATION_HRR	BRCA2 EME1	1.55e-03	70	12	2	M27570
Pathway	WP_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY	DSP CACNA1F	1.73e-03	74	12	2	M39462
Pathway	KEGG_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY_ARVC	DSP CACNA1F	1.73e-03	74	12	2	M16376
Pathway	REACTOME_ORGANELLE_BIOGENESIS_AND_MAINTENANCE	NR1D1 DYNC2I1 HAUS6	1.77e-03	297	12	3	M27050
Pathway	REACTOME_DNA_REPAIR	BRCA2 EME1 MSH2	1.84e-03	301	12	3	MM15433
Pathway	WP_DNA_IRDAMAGE_AND_CELLULAR_RESPONSE_VIA_ATR	BRCA2 MSH2	2.07e-03	81	12	2	M39490
Pathway	REACTOME_DNA_REPAIR	BRCA2 EME1 MSH2	2.43e-03	332	12	3	M15434
Pubmed	Heritable somatic methylation and inactivation of MSH2 in families with Lynch syndrome due to deletion of the 3' exons of TACSTD1.	EPCAM MSH2	2.83e-07	2	19	2	19098912
Pubmed	Genetic variation in genes interacting with BRCA1/2 and risk of breast cancer in the Cypriot population.	BRCA2 EME1 MSH2	7.46e-07	33	19	3	19714462
Pubmed	Exceptions to the rule: case studies in the prediction of pathogenicity for genetic variants in hereditary cancer genes.	BRCA2 MSH2	8.48e-07	3	19	2	25639900
Pubmed	Hereditary ovarian carcinoma: heterogeneity, molecular genetics, pathology, and management.	BRCA2 MSH2	1.70e-06	4	19	2	19383374
Pubmed	The rate of the predominant Jewish mutations in the BRCA1, BRCA2, MSH2 and MSH6 genes in unselected Jewish endometrial cancer patients.	BRCA2 MSH2	1.70e-06	4	19	2	20850175
Pubmed	ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing.	BRCA2 DSP MSH2	3.97e-06	57	19	3	23788249
Pubmed	Higher occurrence of childhood cancer in families with germline mutations in BRCA2, MMR and CDKN2A genes.	BRCA2 MSH2	4.24e-06	6	19	2	18481196
Pubmed	Stabilization of Epithelial β-Catenin Compromises Mammary Cell Fate Acquisition and Branching Morphogenesis.	EPCAM NDNF	2.20e-05	13	19	2	38159590
Pubmed	Noncovalent interactions with SUMO and ubiquitin orchestrate distinct functions of the SLX4 complex in genome maintenance.	EME1 MSH2	2.20e-05	13	19	2	25533185
Pubmed	SLX4 interacts with RTEL1 to prevent transcription-mediated DNA replication perturbations.	EME1 MSH2	2.96e-05	15	19	2	32398829
Pubmed	Grainyhead-like 2 regulates neural tube closure and adhesion molecule expression during neural fold fusion.	EPCAM DSP	5.34e-05	20	19	2	21377456
Pubmed	The human cytoplasmic dynein interactome reveals novel activators of motility.	BRCA2 CENPE DYNC2I1 DSP HAUS6	7.66e-05	853	19	5	28718761
Pubmed	Comprehensive analysis of DNA repair gene polymorphisms and survival in patients with early stage non-small-cell lung cancer.	BRCA2 MSH2	9.12e-05	26	19	2	20731661
Pubmed	Gamma-radiation sensitivity and polymorphisms in RAD51L1 modulate glioma risk.	BRCA2 EME1	9.84e-05	27	19	2	20610542
Pubmed	TRIM29 regulates the assembly of DNA repair proteins into damaged chromatin.	BRCA2 MSH2	1.30e-04	31	19	2	26095369
Pubmed	Genome-wide survey of human alternative pre-mRNA splicing with exon junction microarrays.	NR1D1 CENPE	1.30e-04	31	19	2	14684825
Pubmed	Lynch Syndrome	EPCAM MSH2	1.48e-04	33	19	2	20301390
Pubmed	SLX4IP acts with SLX4 and XPF-ERCC1 to promote interstrand crosslink repair.	EME1 MSH2	1.57e-04	34	19	2	31495888
Pubmed	Polymorphisms in DNA repair and one-carbon metabolism genes and overall survival in diffuse large B-cell lymphoma and follicular lymphoma.	BRCA2 MSH2	1.76e-04	36	19	2	18830263
Pubmed	Phosphoproteome analysis of the human mitotic spindle.	CENPE DSP HAUS6	1.96e-04	210	19	3	16565220
Pubmed	Comprehensive Interactome Mapping of the DNA Repair Scaffold SLX4 Using Proximity Labeling and Affinity Purification.	BRCA2 EME1 MSH2	2.31e-04	222	19	3	37071664
Pubmed	The ATG5 interactome links clathrin-mediated vesicular trafficking with the autophagosome assembly machinery.	NR1D1 HAUS6 CTSZ	2.56e-04	230	19	3	35449600
Pubmed	Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.	BRCA2 CENPE DSP ZMYM6	2.56e-04	588	19	4	38580884
Pubmed	Explorative study to identify novel candidate genes related to oxaliplatin efficacy and toxicity using a DNA repair array.	BRCA2 MSH2	4.13e-04	55	19	2	19536092
Pubmed	Comprehensive analysis of DNA repair gene variants and risk of meningioma.	BRCA2 MSH2	4.43e-04	57	19	2	18270339
Pubmed	Genetic mutations associated with cigarette smoking in pancreatic cancer.	BRCA2 MSH2	5.41e-04	63	19	2	19351817
Cytoband	2p21	EPCAM MSH2	2.93e-04	61	19	2	2p21
Cytoband	Ensembl 112 genes in cytogenetic band chr2p21	EPCAM MSH2	5.03e-04	80	19	2	chr2p21
Cytoband	Ensembl 112 genes in cytogenetic band chr17q21	NR1D1 EME1	1.61e-02	473	19	2	chr17q21
Coexpression	GSE8921_UNSTIM_0H_VS_TLR1_2_STIM_MONOCYTE_12H_UP	BRCA2 CENPE EME1 MSH2	1.14e-05	199	19	4	M6406
Coexpression	BLANCO_MELO_SARS_COV_1_INFECTION_MCR5_CELLS_UP	BRCA2 CENPE	3.27e-05	12	19	2	M34000
Coexpression	FISCHER_DREAM_TARGETS	BRCA2 CENPE EME1 HAUS6 MSH2 METTL16	4.51e-05	969	19	6	M149
Coexpression	HAMAI_APOPTOSIS_VIA_TRAIL_UP	CENPE DYNC2I1 HAUS6 CTSZ MSH2	8.40e-05	656	19	5	M18979
Coexpression	CHIBA_RESPONSE_TO_TSA_DN	BRCA2 DSP	1.04e-04	21	19	2	M12459
Coexpression	HE_LIM_SUN_FETAL_LUNG_C4_CYCLING_NK_CELL	BRCA2 CENPE EME1 HAUS6 MSH2	1.10e-04	694	19	5	M45767
Coexpression	MARSON_BOUND_BY_E2F4_UNSTIMULATED	BRCA2 CENPE EME1 HAUS6 MSH2	1.25e-04	714	19	5	M1744
Coexpression	BROWNE_HCMV_INFECTION_30MIN_DN	BRCA2 CENPE DSP	1.51e-04	145	19	3	M0
Coexpression	LAZARO_GENETIC_MOUSE_MODEL_HIGH_GRADE_LARGE_CELL_NEUROENDOCRINE_LUNG_CARCINOMA_UP	BRCA2 CENPE EPCAM HAUS6	1.76e-04	402	19	4	MM454
Coexpression	HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP	BRCA2 CENPE HAUS6	1.76e-04	153	19	3	M5588
Coexpression	HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP	BRCA2 CENPE HAUS6	1.83e-04	155	19	3	MM1259
Coexpression	HAY_BONE_MARROW_ERYTHROBLAST	BRCA2 CENPE EPCAM EME1 HAUS6 MSH2	2.02e-04	1271	19	6	M39197
Coexpression	AIGNER_ZEB1_TARGETS	EPCAM DSP	2.92e-04	35	19	2	M14590
Coexpression	RPS14_DN.V1_DN	CENPE EPCAM MSH2	3.13e-04	186	19	3	M2812
Coexpression	GSE13547_CTRL_VS_ANTI_IGM_STIM_BCELL_12H_UP	BRCA2 CENPE EME1	3.18e-04	187	19	3	M2984
Coexpression	GSE30962_PRIMARY_VS_SECONDARY_ACUTE_LCMV_INF_CD8_TCELL_UP	CENPE EME1 DEUP1	3.88e-04	200	19	3	M5041
Coexpression	GSE22103_UNSTIM_VS_GMCSF_AND_IFNG_STIM_NEUTROPHIL_DN	BRCA2 CENPE MSH2	3.88e-04	200	19	3	M7792
Coexpression	GSE16522_MEMORY_VS_NAIVE_CD8_TCELL_DN	EPCAM DSP MARCHF10	3.88e-04	200	19	3	M3659
Coexpression	HALLMARK_E2F_TARGETS	BRCA2 CENPE MSH2	3.88e-04	200	19	3	M5925
Coexpression	GSE10239_NAIVE_VS_KLRG1HIGH_EFF_CD8_TCELL_DN	BRCA2 EME1 MARCHF10	3.88e-04	200	19	3	M3054
Coexpression	WHITFIELD_CELL_CYCLE_LITERATURE	BRCA2 MSH2	4.62e-04	44	19	2	M2066
Coexpression	KAUFFMANN_DNA_REPAIR_GENES	BRCA2 EME1 MSH2	5.82e-04	230	19	3	M11563
Coexpression	FEVR_CTNNB1_TARGETS_DN	BRCA2 CENPE HAUS6 MSH2	5.98e-04	555	19	4	M2343
Coexpression	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP	BRCA2 CENPE EME1 HAUS6	6.97e-04	578	19	4	M2368
Coexpression	MEBARKI_HCC_PROGENITOR_FZD8CRD_UP	BRCA2 CENPE HAUS6 MSH2	7.43e-04	588	19	4	M38992
Coexpression	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP	BRCA2 CENPE EME1 HAUS6	7.87e-04	597	19	4	MM1309
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000_k-means-cluster#3	BRCA2 CENPE DYNC2I1 EME1 HAUS6	2.04e-06	246	19	5	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000_K3
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_500	BRCA2 CENPE DYNC2I1 EME1 DEUP1 MARCHF10	3.19e-06	493	19	6	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_500
CoexpressionAtlas	FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_1000	BRCA2 CENPE EPCAM CACNA1F EME1 DEUP1 MARCHF10	1.34e-05	979	19	7	Facebase_RNAseq_e10.5_Medial Nasal Eminence_1000
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000	BRCA2 CENPE DYNC2I1 EME1 HAUS6 DEUP1 MARCHF10	1.38e-05	983	19	7	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000
CoexpressionAtlas	FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_500_k-means-cluster#5	BRCA2 CENPE DYNC2I1 EME1	1.99e-05	186	19	4	Facebase_RNAseq_e10.5_Mandibular Arch_500_K5
CoexpressionAtlas	FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_500_k-means-cluster#4	BRCA2 CENPE DYNC2I1 EME1	2.26e-05	192	19	4	Facebase_RNAseq_e10.5_Lateral Nasal Eminence_500_K4
CoexpressionAtlas	FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_1000_k-means-cluster#5	BRCA2 NDNF EME1 HAUS6	2.86e-05	204	19	4	Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_1000_K5
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_500_k-means-cluster#5	BRCA2 CENPE DYNC2I1 EME1	4.73e-05	232	19	4	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_500_K5
CoexpressionAtlas	FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_500	BRCA2 CENPE DYNC2I1 CACNA1F MARCHF10	5.82e-05	492	19	5	Facebase_RNAseq_e10.5_Maxillary Arch_500
CoexpressionAtlas	FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3	BRCA2 CENPE NDNF EME1 HAUS6	8.42e-05	532	19	5	Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3
CoexpressionAtlas	FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_1000_k-means-cluster#3	BRCA2 CENPE DYNC2I1 EME1	1.14e-04	291	19	4	Facebase_RNAseq_e10.5_Lateral Nasal Eminence_1000_K3
CoexpressionAtlas	EB blastocyst_vs_EB amniotic fluid MSC-Confounder_removed-fold2.0_adjp0.05	EPCAM DSP NDNF CTSZ	1.28e-04	300	19	4	PCBC_ratio_EB blastocyst_vs_EB amniotic fluid MSC_cfr-2X-p05
CoexpressionAtlas	kidney_P3_CapMes_Crym_k-means-cluster#4_top-relative-expression-ranked_1000	EPCAM NDNF EME1 HAUS6	1.56e-04	316	19	4	gudmap_kidney_P3_CapMes_Crym_k4_1000
CoexpressionAtlas	dev gonad_e11.5_M_PrimGermCell_Oct_top-relative-expression-ranked_500	BRCA2 EPCAM DSP MSH2	3.04e-04	376	19	4	gudmap_dev gonad_e11.5_M_PrimGermCell_Oct_500
CoexpressionAtlas	dev gonad_e11.5_F_PrimGermCell_Oct_top-relative-expression-ranked_500	BRCA2 EPCAM DSP MSH2	3.36e-04	386	19	4	gudmap_dev gonad_e11.5_F_PrimGermCell_Oct_500
CoexpressionAtlas	dev gonad_e12.5_F_GermCellOvary_Oct_top-relative-expression-ranked_500	BRCA2 EPCAM DSP MSH2	4.06e-04	406	19	4	gudmap_dev gonad_e12.5_F_GermCellOvary_Oct_500
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000_k-means-cluster#1	BRCA2 CENPE DEUP1	4.15e-04	166	19	3	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000_K1
CoexpressionAtlas	alpha beta T cells, T.8Eff.Sp.OT1.d5.VSVOva, CD8+ CD45.1+, Spleen, avg-3	BRCA2 CENPE EME1 HAUS6	4.22e-04	410	19	4	GSM538387_500
CoexpressionAtlas	dev gonad_e11.5_M_PrimGermCell_Oct_top-relative-expression-ranked_1000	BRCA2 EPCAM DSP MSH2 METTL16	5.03e-04	781	19	5	gudmap_dev gonad_e11.5_M_PrimGermCell_Oct_1000
CoexpressionAtlas	facebase_RNAseq_e10.5_MandArch_2500_K1	BRCA2 CENPE DYNC2I1 NDNF EME1 HAUS6	5.52e-04	1241	19	6	facebase_RNAseq_e10.5_MandArch_2500_K1
CoexpressionAtlas	facebase_RNAseq_e10.5_MaxArch_2500_K3	BRCA2 CENPE DYNC2I1 NDNF EME1 HAUS6	5.79e-04	1252	19	6	facebase_RNAseq_e10.5_MaxArch_2500_K3
CoexpressionAtlas	dev gonad_e13.5_M_GermCell_Oct_top-relative-expression-ranked_1000	BRCA2 EPCAM ZMYM6 MSH2 METTL16	5.94e-04	810	19	5	gudmap_dev gonad_e13.5_M_GermCell_Oct_1000
CoexpressionAtlas	dev gonad_e13.5_F_MeioticGermCell_Oct_top-relative-expression-ranked_1000	BRCA2 EPCAM DSP ZMYM6 MSH2	6.28e-04	820	19	5	gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_1000
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500_k-means-cluster#3	BRCA2 CENPE EME1	6.34e-04	192	19	3	Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500_K3
CoexpressionAtlas	dev gonad_e12.5_F_GermCellOvary_Oct_top-relative-expression-ranked_1000	BRCA2 EPCAM DSP MSH2 METTL16	6.35e-04	822	19	5	gudmap_dev gonad_e12.5_F_GermCellOvary_Oct_1000
CoexpressionAtlas	FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#1	BRCA2 CENPE NDNF EME1	7.00e-04	469	19	4	Facebase_RNAseq_e8.5_Floor Plate_2500_K1
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_500_k-means-cluster#3	DEUP1 MARCHF10	8.01e-04	47	19	2	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_500_K3
CoexpressionAtlas	FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_500	EPCAM CACNA1F DEUP1 MARCHF10	8.12e-04	488	19	4	Facebase_RNAseq_e10.5_Medial Nasal Eminence_500
CoexpressionAtlas	FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_500	BRCA2 CENPE DYNC2I1 EME1	8.37e-04	492	19	4	Facebase_RNAseq_e10.5_Mandibular Arch_500
CoexpressionAtlas	FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_500	BRCA2 CENPE DYNC2I1 EME1	8.37e-04	492	19	4	Facebase_RNAseq_e10.5_Lateral Nasal Eminence_500
CoexpressionAtlas	facebase_RNAseq_e8.5_FloorPlate_2500_K3	BRCA2 CENPE NDNF EME1 HAUS6 METTL16	9.36e-04	1371	19	6	facebase_RNAseq_e8.5_FloorPlate_2500_K3
CoexpressionAtlas	dev gonad_e12.5_F_GermCellOvary_Oct_k-means-cluster#4_top-relative-expression-ranked_1000	EPCAM MSH2 METTL16	1.25e-03	243	19	3	gudmap_dev gonad_e12.5_F_GermCellOvary_Oct_k4_1000
CoexpressionAtlas	facebase_RNAseq_e10.5_Emin_LatNas_2500	BRCA2 CENPE DYNC2I1 EME1 HAUS6 DEUP1	1.30e-03	1459	19	6	facebase_RNAseq_e10.5_Emin_LatNas_2500
CoexpressionAtlas	facebase_RNAseq_e10.5_MandArch_2500	BRCA2 CENPE DYNC2I1 NDNF EME1 HAUS6	1.34e-03	1468	19	6	facebase_RNAseq_e10.5_MandArch_2500
CoexpressionAtlas	kidney_P4_CapMesRenVes_Crym_k-means-cluster#3_top-relative-expression-ranked_200	EPCAM NDNF	1.39e-03	62	19	2	gudmap_kidney_P4_CapMesRenVes_Crym_k3_200
CoexpressionAtlas	FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_1000	BRCA2 CENPE DYNC2I1 EME1 MARCHF10	1.43e-03	985	19	5	Facebase_RNAseq_e10.5_Lateral Nasal Eminence_1000
CoexpressionAtlas	FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_500_k-means-cluster#3	BRCA2 CENPE DYNC2I1	1.44e-03	255	19	3	Facebase_RNAseq_e10.5_Maxillary Arch_500_K3
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000	BRCA2 CENPE EPCAM EME1 DEUP1	1.44e-03	986	19	5	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000
CoexpressionAtlas	FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000	BRCA2 CENPE DYNC2I1 CACNA1F MARCHF10	1.46e-03	989	19	5	Facebase_RNAseq_e10.5_Maxillary Arch_1000
CoexpressionAtlas	FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_1000_k-means-cluster#3	CENPE DYNC2I1 EME1	1.71e-03	271	19	3	Facebase_RNAseq_e10.5_Mandibular Arch_1000_K3
CoexpressionAtlas	Stromal Cells, Ep.MEChi.Th, CD45- EpCAm+ Ly51- MHCIIhi, Thymus, avg-2	EPCAM DSP	1.77e-03	70	19	2	GSM777041_100
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_2500_k-means-cluster#2	BRCA2 CENPE DYNC2I1 EME1	1.82e-03	607	19	4	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_2500_K2
CoexpressionAtlas	BM Top 100 - thyroid gland	EPCAM DSP	1.92e-03	73	19	2	BM Top 100 - thyroid gland
CoexpressionAtlas	facebase_RNAseq_e10.5_Emin_MedNas_2500_K1	BRCA2 CENPE DYNC2I1 EME1 DEUP1	1.99e-03	1060	19	5	facebase_RNAseq_e10.5_Emin_MedNas_2500_K1
CoexpressionAtlas	BM Top 100 - prostate gland	EPCAM DSP	2.08e-03	76	19	2	BM Top 100 - prostate gland
CoexpressionAtlas	Stromal Cells, Ep.MEChi.Th, CD45-EpCAm+Ly51-MHCIIhi, Thymus, avg-1	EPCAM DSP	2.13e-03	77	19	2	GSM854302_100
CoexpressionAtlas	FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_1000_k-means-cluster#4	BRCA2 CENPE EME1	2.24e-03	298	19	3	Facebase_RNAseq_e10.5_Medial Nasal Eminence_1000_K4
CoexpressionAtlas	BM Top 100 - salivary gland	EPCAM DSP	2.30e-03	80	19	2	BM Top 100 - salivary gland
CoexpressionAtlas	FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_500_k-means-cluster#4	HAUS6 MARCHF10	2.41e-03	82	19	2	Facebase_RNAseq_e9.5_Mandibular Arch_500_K4
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2	BRCA2 CENPE EME1	2.53e-03	311	19	3	Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2
CoexpressionAtlas	dev gonad_e11.5_M_PrimGermCell_Oct_k-means-cluster#4_top-relative-expression-ranked_1000	EPCAM MSH2 METTL16	2.63e-03	315	19	3	gudmap_dev gonad_e11.5_M_PrimGermCell_Oct_k4_1000
ToppCell	5'-Airway_Nasal-Epithelial-Neuro-endocrine/ionocytic-ionocyte-Ionocyte\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	FSIP2 EPCAM DSP MARCHF10	9.37e-07	181	19	4	2b53a65ca5616a7b9f64232c3e0b7212d1e2f063
ToppCell	5'-Airway_Nasal-Epithelial-Neuro-endocrine/ionocytic-ionocyte\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	FSIP2 EPCAM DSP MARCHF10	9.37e-07	181	19	4	6aef84616e8d2faf54b7e9e6cd02f33c3066dabc
ToppCell	5'-Airway_Nasal-Epithelial-Neuro-endocrine/ionocytic-ionocyte-Ionocyte-Ionocyte_L.0.7.0.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	FSIP2 EPCAM DSP MARCHF10	9.37e-07	181	19	4	40df0afcb6848202da54670e84f22d7c3a515d01
ToppCell	5'-Airway_Nasal-Epithelial-Neuro-endocrine/ionocytic\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	FSIP2 EPCAM DSP MARCHF10	9.37e-07	181	19	4	40d3829ae4aaf81e8616c3499ff8933137fc1cc4
ToppCell	3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_proliferating-\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	BRCA2 CENPE EME1 HAUS6	1.21e-06	193	19	4	e45ce9cf8421512b57f157c24b64793b47b4ba4b
ToppCell	LPS_IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	EPCAM DSP NDNF CACNA1F	1.31e-06	197	19	4	b94645d57efe8d9e032bffb8c89af1f425c6421e
ToppCell	LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT2\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	EPCAM DSP NDNF CACNA1F	1.31e-06	197	19	4	3d13a4f2e86422900ee2194e8a1fd1cf9750d5d3
ToppCell	LPS_IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT1\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	EPCAM DSP NDNF CACNA1F	1.34e-06	198	19	4	b598ab958e31f1e98bd06dc0097b58ac3a3f90a3
ToppCell	LPS_IL1RA-Epithelial_alveolar-AT_1\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	EPCAM DSP NDNF CACNA1F	1.37e-06	199	19	4	a270630626df614f8605abddb7dee7c4d74f6149
ToppCell	Bronchial-NucSeq-Epithelial-Epi_alveolar-Dividing_AT2\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	BRCA2 CENPE EME1 MSH2	1.37e-06	199	19	4	1d5a3366474c17e3df0ba5cf11b586655529e9bd
ToppCell	LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT1\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	EPCAM DSP NDNF CACNA1F	1.37e-06	199	19	4	d43c605a4ff221cf78d91678c15d2ad20f831c7f
ToppCell	Bronchial-10x5prime-Immune_Myeloid-Macrophage_alveolar-Macro_alv_dividing\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	BRCA2 EME1 CTSZ MSH2	1.37e-06	199	19	4	e1190b1c2d21fed313bb58e24d0e6365de6e6599
ToppCell	Parenchymal-NucSeq-Epithelial-Epi_alveolar-Dividing_AT2\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	BRCA2 CENPE EME1 MSH2	1.39e-06	200	19	4	af3dc76b4507bf4edd265169f5dfbbb8a19eb394
ToppCell	LPS_IL1RA_TNF-Epithelial_alveolar-AT_1-Differentiating_AT1\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	EPCAM DSP NDNF CACNA1F	1.39e-06	200	19	4	ddfb1f006365bf16203ee49f20200f68220cc288
ToppCell	LPS_anti-TNF-Epithelial_alveolar-AT_1\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	EPCAM DSP NDNF CACNA1F	1.39e-06	200	19	4	8683445ad5b70748c4a1f12eb77d47623085147e
ToppCell	NS-critical-d_0-4-Myeloid-pDC\|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	CENPE ANKRD62 EME1	3.00e-05	144	19	3	0fde5cd82df9b90aefde19275cff6c2ec3c9d5cb
ToppCell	Epithelial-B_(AT1-AT2-progenitors)\|World / shred on cell class and cell subclass (v4)	EPCAM DSP NDNF	3.12e-05	146	19	3	4511916904c1fac252cb68e871b782207f8137b3
ToppCell	COVID-19-Epithelial_cells-Airway_mucous\|COVID-19 / group, cell type (main and fine annotations)	EPCAM DSP MARCHF10	3.45e-05	151	19	3	8216462e723fec2797387929dde095370947e10a
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	BRCA2 CENPE EME1	3.80e-05	156	19	3	b3f10cd044f24807576e7d56e51df7064dbf6c50
ToppCell	LPS-IL1RA-Epithelial_alveolar-AT_1-AT1\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	EPCAM DSP NDNF	4.18e-05	161	19	3	1e17a993126e1f2a25ee7dfbb95a74ccb2a26791
ToppCell	PND03-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2-AT1/AT2_mature\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	EPCAM DSP NDNF	4.26e-05	162	19	3	d0d9c18a73bc0bf4f38308ef2eee8ae20f6a7918
ToppCell	PND03-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	EPCAM DSP NDNF	4.26e-05	162	19	3	06f5d6c0bb26fe9d5180bc2ebf2c54bf52e715f3
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	BRCA2 CENPE EME1	4.33e-05	163	19	3	3f434015c0cbefb31eeda133c34f75384c5f7e22
ToppCell	10x5'-Liver-Hematopoietic_progenitors\|Liver / Manually curated celltypes from each tissue	BRCA2 CENPE EME1	4.58e-05	166	19	3	ae967570248cf86ca3ddf55e33bcbb3e4e3684bc
ToppCell	10x5'-Liver-Hematopoietic_progenitors-Cycling_pre-Myeloid-2\|Liver / Manually curated celltypes from each tissue	BRCA2 CENPE EME1	4.58e-05	166	19	3	a176e87aa6eec81d1fb79a028f759182d11b567d
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	BRCA2 CENPE EME1	4.83e-05	169	19	3	b253a4a50c06d36228fcd5d856c57202cbac158f
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	BRCA2 CENPE EME1	4.83e-05	169	19	3	54b13ab02b4c187f4754045ecfcf409749e7ccc0
ToppCell	Control-Epithelial_alveolar-AT_1-AT1_Progenitor\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	EPCAM DSP NDNF	4.91e-05	170	19	3	bfce0984b41e0c532e7ba264972593a382f0637c
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	BRCA2 CENPE EME1	5.17e-05	173	19	3	a25459b8140b0dbcb73e3b4cc1407b679229f25c
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	BRCA2 CENPE EME1	5.26e-05	174	19	3	7b318796728001c17b4043d2b033330c7be40c78
ToppCell	PND10-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	EPCAM DSP NDNF	5.35e-05	175	19	3	442f261a3b2c4d2523f7d4089178f8c79cac2f0f
ToppCell	Dividing_Macrophages-IPF_03\|World / lung cells shred on cell class, cell subclass, sample id	BRCA2 CENPE EME1	5.35e-05	175	19	3	0a8bf455babb3271aa00642199fb58b0b02dc3ac
ToppCell	PND10-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2-AT1/AT2_mature\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	EPCAM DSP NDNF	5.35e-05	175	19	3	35fb7735dd3355476fe60404833cb60bd066bcf1
ToppCell	P03-Epithelial-airway_epithelial_cell-ciliated_cell_of_airway\|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	EPCAM DSP NDNF	5.45e-05	176	19	3	f3a54038cde58326f1caed96ecca33c141bcc8b3
ToppCell	PND10-Immune-Immune_Myeloid-Monocytic-Macrophage-iMON-iMON_G2M\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CENPE EME1 ZMYM6	5.45e-05	176	19	3	90f8bb11f339f67f08692a0c33dd420f5cda2861
ToppCell	PND14-Immune-Immune_Myeloid-Monocytic-Macrophage-AM\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	NR1D1 CENPE CTSZ	5.54e-05	177	19	3	67cc3a6461db5e0678f96b18224aeb83ad34b0f4
ToppCell	Control-Epithelial_alveolar-AT_1-Differentiating_AT1\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	EPCAM DSP NDNF	5.54e-05	177	19	3	9af14a056eb6d88c6f11b09f6d4c0d3448d647d5
ToppCell	Control-Epithelial_alveolar-AT_1\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	EPCAM DSP NDNF	5.63e-05	178	19	3	aa7d43c655df493f1330a5001efaa484e4a19f69
ToppCell	Control-Epithelial_alveolar-AT_1-AT1\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	EPCAM DSP NDNF	5.63e-05	178	19	3	1817bc520f3d23da8c0fa09bba50ae703a820cb1
ToppCell	10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_INF-A\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	BRCA2 CTSZ ZMYM6	5.73e-05	179	19	3	06d412fc096d88de168969466ce422f0ab5553b2
ToppCell	NS-critical-LOC-Epithelial-Ionocyte\|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	EPCAM DSP MARCHF10	5.73e-05	179	19	3	65a96bee7bc28f5bfc20f0fd92bcc0ab2eb5e06c
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell_cycling\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	BRCA2 CENPE EME1	5.82e-05	180	19	3	401df9cddcbca1eb8f0d2687bcacd98e95dc1493
ToppCell	LPS-IL1RA-Endothelial-Endothelial-FOXM1\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	BRCA2 CENPE EME1	5.82e-05	180	19	3	334e2b1f6eb7d4ece20b1c7b02107863f913237f
ToppCell	LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DSP NDNF CACNA1F	5.92e-05	181	19	3	b45b11428d13950369347e051d4d517efb2bd4fd
ToppCell	Control-Epithelial_alveolar-AT_1-AT1-AT2\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	EPCAM DSP NDNF	6.02e-05	182	19	3	a95956ce4adccb34cc0c47ebfa1878ce4617904e
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell_cycling-Cycling_Connecting_Tubule_Cell_G2M\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	BRCA2 CENPE EME1	6.02e-05	182	19	3	336cd05e46a741185ce3c59ee67a4b07fa6a5101
ToppCell	10x5'-Liver-Lymphocytic_T_CD4/8-lo-Cycling_T\|Liver / Manually curated celltypes from each tissue	BRCA2 CENPE ANKRD62	6.02e-05	182	19	3	81557cdc88777f3bd4e1dd18a760b08fc29122ef
ToppCell	LPS-IL1RA-Epithelial_alveolar-AT_1-AT1-AT2\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	EPCAM DSP NDNF	6.02e-05	182	19	3	cc79e0cc21e2fdc4ef77f052818d27b9f707aec1
ToppCell	LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-AT1-AT2\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	EPCAM DSP NDNF	6.11e-05	183	19	3	06ac66726ec53db810ebb90ec69cfdb903da53f6
ToppCell	LPS-antiTNF-Epithelial_alveolar-AT_1\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	EPCAM DSP NDNF	6.11e-05	183	19	3	ff6dde877659cde9daa3263db0932c9c9ef1adac
ToppCell	TCGA-Liver-Primary_Tumor-Hepatocellular_Carcinoma-Hepatocellular_Carcinoma-5\|TCGA-Liver / Sample_Type by Project: Shred V9	BRCA2 CENPE EME1	6.11e-05	183	19	3	f604a8b62c7088fad8365dbf8d910fc980bd3ba8
ToppCell	LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-AT1\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	EPCAM DSP NDNF	6.11e-05	183	19	3	274483009b309289e4cb84beedf6806430db6ff6
ToppCell	LPS-IL1RA-Epithelial_alveolar-AT_1\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	EPCAM DSP NDNF	6.21e-05	184	19	3	cdf6f1c6cce97a7effa0c55959652e2c0b6992b3
ToppCell	LPS-antiTNF-Epithelial_alveolar-AT_1-AT2_Progenitor\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	EPCAM DSP NDNF	6.21e-05	184	19	3	7cc5796557379c3d1db078c1aeda40659c6e401c
ToppCell	PND01-03-samps-Epithelial\|PND01-03-samps / Age Group, Lineage, Cell class and subclass	EPCAM DSP NDNF	6.31e-05	185	19	3	2b854df79cfe2cb4d2f9c2938a066e0aa3649325
ToppCell	LPS-antiTNF-Epithelial_alveolar-AT_1-AT1-AT2\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	EPCAM DSP NDNF	6.31e-05	185	19	3	3bef59cc0aa939d2a7e52f0f6c61bc00528fe50b
ToppCell	LPS_only-Epithelial_alveolar-AT_1-AT1\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	EPCAM DSP NDNF	6.31e-05	185	19	3	0c247a3f394c42e2a6f67fee3d9cf33096fecd13
ToppCell	LPS_only-Epithelial_alveolar-AT_1-AT1-AT2\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	EPCAM DSP NDNF	6.31e-05	185	19	3	68f428e169cfb77de970bdfdeea9b9f16f68d2ba
ToppCell	Control-Epithelial_alveolar\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	EPCAM DSP NDNF	6.31e-05	185	19	3	3937e026add96a396122139daf8011cfbc60e75c
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	BRCA2 CENPE EME1	6.31e-05	185	19	3	30e041d6f6e310d64809e9d6d93cd30052972f3b
ToppCell	LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	EPCAM DSP NDNF	6.31e-05	185	19	3	c82eab551f65ecebe6db908eda9f9eb3414693c7
ToppCell	droplet-Lung-3m-Hematologic-myeloid-alveolar_macrophage-proliferating_alveolar_macrophage\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	NR1D1 CENPE EPCAM	6.31e-05	185	19	3	57c1eb50a4456d20953e48d5dc3b0ea3d0d81b6d
ToppCell	368C-Myeloid-Dendritic-cDC_proliferating_1\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	CENPE EME1 MSH2	6.42e-05	186	19	3	799903b68bc6f6205d004b44c603424b0d5f7c32
ToppCell	E15.5-Epithelial-airway_epithelial_cell\|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	EPCAM DSP DEUP1	6.42e-05	186	19	3	bb2c7af3b1d8478c49a8626dbfd6c92c5e7adc4a
ToppCell	LPS_only-Epithelial_alveolar\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	EPCAM DSP NDNF	6.42e-05	186	19	3	e0a2ea4b46af742bc7c9b2072bb85e27d5c92712
ToppCell	E15.5-Epithelial-airway_epithelial_cell-club_cell\|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	EPCAM DSP DEUP1	6.42e-05	186	19	3	86c809b99088d3d6c8f87785797c4beefdcddbe7
ToppCell	368C-Myeloid-Dendritic-cDC_proliferating_1\|Dendritic / Donor, Lineage, Cell class and subclass (all cells)	CENPE EME1 MSH2	6.42e-05	186	19	3	5cadab3271fce9ab6da3d7ba9827b8a221cac166
ToppCell	LPS_only-Epithelial_alveolar-AT_1\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	EPCAM DSP NDNF	6.52e-05	187	19	3	ff26a533d310126521efe1d05cf8b9d32e524550
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	BRCA2 CENPE EME1	6.52e-05	187	19	3	9351fa87b69a951af85b10bf91fe9b1cce8c0517
ToppCell	LPS-antiTNF-Epithelial_alveolar\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	EPCAM DSP NDNF	6.52e-05	187	19	3	201ff693e4756ee3e44762885b3a303a77eb535b
ToppCell	PND01-03-samps-Epithelial-Alveolar_epithelial\|PND01-03-samps / Age Group, Lineage, Cell class and subclass	EPCAM DSP NDNF	6.52e-05	187	19	3	23fe3cdd6cc9b067086a8392d104186d300298ea
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell_cycling\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	BRCA2 CENPE EME1	6.52e-05	187	19	3	057569c9437219ecc396aa6e673b1178a2273837
ToppCell	COVID-19-Epithelial-Ionocytes\|COVID-19 / Condition, Lineage and Cell class	EPCAM DSP MARCHF10	6.62e-05	188	19	3	a581cb9528d0febbf3addbb4f6bc140f91a584e6
ToppCell	LPS-IL1RA+antiTNF-Epithelial_alveolar\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	EPCAM DSP NDNF	6.62e-05	188	19	3	43a0508d2524a5b310e89e9422843dcaab999bc3
ToppCell	Multiple_Sclerosis-Lymphocyte-T_NK-T_NK_proliferative\|Multiple_Sclerosis / Disease, Lineage and Cell Type	BRCA2 CENPE EME1	6.62e-05	188	19	3	6c05797a5d0635d89ffcf4aca52178687129ccb4
ToppCell	Dividing_Macrophages-SSc-ILD_02\|World / lung cells shred on cell class, cell subclass, sample id	BRCA2 CENPE EME1	6.73e-05	189	19	3	d4e88a3e50499d683e3db38aee04490146fe30bb
ToppCell	Int-URO-Lymphocyte-T_NK-T_NK_proliferative\|Int-URO / Disease, Lineage and Cell Type	BRCA2 CENPE EME1	6.83e-05	190	19	3	005967c540418b85311308072a07c684f4296aef
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Immune-Lymphocytic_T/NK-Cycling_Natural_Killer_Cell_/_Natural_Killer_T_Cell-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	BRCA2 CENPE EME1	6.83e-05	190	19	3	185ae04c68f825cd346aa65072cc5da6a39dff4a
ToppCell	PBMC-Severe-Myeloid-Neutrophil-Neutrophil-Neu_4\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	BRCA2 CENPE HAUS6	6.83e-05	190	19	3	3f0c7d130f66faea778fe567604edf1b4cdf85b3
ToppCell	pdx-Tumor_cells-T1\|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)	BRCA2 CENPE MSH2	6.83e-05	190	19	3	d06ee5f89f1cec8db6897fe3b2a890a07cd3697b
ToppCell	PBMC-Severe-cDC_12\|Severe / Compartment, Disease Groups and Clusters	BRCA2 HAUS6 MSH2	6.83e-05	190	19	3	84ee185939bdefb10705b621a70da27701eadcee
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Immune-Lymphocytic_T/NK-Cycling_Natural_Killer_Cell_/_Natural_Killer_T_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	BRCA2 CENPE EME1	6.83e-05	190	19	3	e38dc41f2e79e3bd51326581c6ebe51927edb549
ToppCell	saliva-Severe-critical_progression_d12-22_no-steroids-Epithelial-Epithelial,_Airway-ciliated_cell\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	EPCAM DSP MARCHF10	7.05e-05	192	19	3	dcf2d0c2e8868104c4dba410456207f0d947029a
ToppCell	PCW_07-8.5-Epithelial-Epithelial_proliferating-epi_proliferating2_(13)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	CENPE EPCAM DSP	7.05e-05	192	19	3	25378b5e4b0cea8415ff125783511fc25a56fc00
ToppCell	PND03-Epithelial\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	EPCAM DSP NDNF	7.05e-05	192	19	3	d8c23693f690d4d568585537bbfedda05d505b3d
ToppCell	saliva-Severe-critical_progression_d12-22_no-steroids-Epithelial-Epithelial,_Airway-ciliated_cell-Epi-Ciliated\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	EPCAM DSP MARCHF10	7.05e-05	192	19	3	a22952b885c8a7704a4a9602fa03e4f2c786bf75
ToppCell	PBMC-Severe-Myeloid-Neutrophil-Neutrophil-Neu_4\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	BRCA2 CENPE HAUS6	7.05e-05	192	19	3	c09dcc73ff9c3855a0f3d7bfa0d5c99c09a117f2
ToppCell	PND03-Epithelial-Epithelial_Alveolar\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	EPCAM DSP NDNF	7.16e-05	193	19	3	5dfa69a680a0859900141c40a446d217aaa747d3
ToppCell	5'-GW_trimst-2-SmallIntestine-Epithelial-goblet\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	EPCAM DSP CACNA1F	7.16e-05	193	19	3	402aad2f9e789ad1f2e1536cdc9ce61de7625427
ToppCell	PND03-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	EPCAM DSP NDNF	7.16e-05	193	19	3	ebea35704ac5d21e947ae094313cf2a5205e7014
ToppCell	PSB-critical-LOC-Epithelial-FOXN4+\|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	BRCA2 EME1 DEUP1	7.16e-05	193	19	3	b7d9c5bed524423e92f01496a9f8fad11b33a3f7
ToppCell	3'-Distal_airway-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_proliferating-\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	BRCA2 CENPE EME1	7.16e-05	193	19	3	444de545117dae8ab24a22880583ac2f0b2d6eac
ToppCell	human_hepatoblastoma-Tumor_cells-T1\|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)	BRCA2 CENPE MSH2	7.16e-05	193	19	3	4b9fa2a4424f8abe63fa7bee78db93dda04ab15f
ToppCell	5'-GW_trimst-2-SmallIntestine-Epithelial-goblet-Goblet_cell\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	EPCAM DSP CACNA1F	7.16e-05	193	19	3	7ee3b1ef5c455f321b4e154ae62c69543fe9b30e
ToppCell	PBMC-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	BRCA2 CENPE EME1	7.27e-05	194	19	3	f39a471293ecc5c5967b00e772b8f48ebc9affbe
ToppCell	systemic_lupus_erythematosus-flare-Lymphocytic\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	BRCA2 CENPE EME1	7.27e-05	194	19	3	17af04acd54dd6a895a966cbb4422de25dc4f1e6
ToppCell	PBMC-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	BRCA2 CENPE EME1	7.27e-05	194	19	3	a75ecd0b0a928d4646602f7d16a645f6b3df3af5
ToppCell	5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_proliferating-Alveolar_macrophage_proliferating_L.1.0.7.3\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	BRCA2 CENPE EME1	7.27e-05	194	19	3	e5b81a8e52259a54a911c1c2ac932c98c988318d
ToppCell	PCW_13-14-Epithelial-Epithelial_proliferating-epi_proliferating2_(13)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	CENPE EPCAM DSP	7.27e-05	194	19	3	c197e4acbff42a9f0410b6801c2bfcf6160aefc1
ToppCell	PBMC-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	BRCA2 CENPE EME1	7.27e-05	194	19	3	17744fd6645cf5a447a01a83f07e8d305c2bcd9c
Disease	Breast Cancer, Familial	BRCA2 EPCAM MSH2	5.26e-07	30	16	3	C0346153
Disease	ovarian neoplasm	BRCA2 EPCAM HAUS6 MSH2	7.09e-07	134	16	4	C0919267
Disease	Malignant neoplasm of ovary	BRCA2 EPCAM HAUS6 MSH2	7.75e-07	137	16	4	C1140680
Disease	Lynch syndrome I (site-specific colonic cancer)	EPCAM MSH2	8.27e-07	3	16	2	C2931459
Disease	Adult only	BRCA2 MSH2	4.13e-06	6	16	2	C3842001
Disease	Lynch Syndrome	EPCAM MSH2	9.90e-06	9	16	2	C4552100
Disease	Hereditary Nonpolyposis Colorectal Neoplasms	EPCAM MSH2	8.89e-05	26	16	2	C0009405
Disease	Hereditary non-polyposis colorectal cancer syndrome	EPCAM MSH2	9.60e-05	27	16	2	C1112155
Disease	Hereditary Nonpolyposis Colorectal Cancer	EPCAM MSH2	1.11e-04	29	16	2	C1333990
Disease	Neoplasm of uncertain or unknown behavior of ovary	BRCA2 MSH2	1.11e-04	29	16	2	C0496920
Disease	Ovarian Carcinoma	BRCA2 MSH2	1.19e-04	30	16	2	C0029925
Disease	esophagus squamous cell carcinoma (is_implicated_in)	BRCA2 MSH2	2.69e-04	45	16	2	DOID:3748 (is_implicated_in)
Disease	Prostate cancer, familial	BRCA2 HAUS6	6.33e-04	69	16	2	C2931456
Disease	Glioma	BRCA2 MSH2	1.00e-03	87	16	2	C0017638

Protein segments in the cluster

Peptide	Gene	Start	Entry
NYKLAVNCFVNNNRQ	EPCAM	31	P16422
NYQAKDQECDKFNQC	CTSZ	156	Q9UBR2
YQQQCNDARKKADNQ	ANKRD62	786	A6NC57
EKCNQFQKQAQSYQT	DEUP1	176	Q05D60
QEYQNCELDKNQRQC	CACNA1F	1146	O60840
KNTKQAYVQCNEDNV	DYNC2I1	526	Q8WVS4
RCQNVSDKQNQAKLY	FSIP2	5811	Q5CZC0
DDNYNEDQKKREQNQ	NDNF	486	Q8TB73
DMCFNYAKKNVEQNN	METTL16	136	Q86W50
CFLANQQNKYKNEEC	NBPF1	591	Q3BBV0
QQNIQYKRCLKNENC	NR1D1	161	P20393
EKNQDVCALNENYKN	BRCA2	816	P51587
NCNKNKFLDQNLQKY	DSP	1051	P15924
QAKNKNFEENAENCR	MARCHF10	326	Q8NA82
QRQDCVTQKYQENAQ	HAUS6	181	Q7Z4H7
VQAYQQCFSDKERQN	EME1	511	Q96AY2
AKKFQRQAANLQDCY	MSH2	391	P43246
KENDRICQVNNFFNN	CENPE	2291	Q02224
CQKNADTRFEVKYQN	ZMYM6	196	O95789